Centaurus Financial’s VanEck Pharmaceutical ETF PPH Stock Holding History

Centaurus Financial’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$139K	Buy	+1,273	New	+$132K	0.01%	995
2024 Q4	–	Sell	-1,440	Closed	-$137K	–	918
2024 Q3	$137K	Sell	1,440 -20	-1%	-$1.9K	0.01%	751
2024 Q2	$134K	Buy	1,460 +70	+5%	+$6.25K	0.01%	710
2024 Q1	$126K	Buy	+1,390	New	+$122K	0.01%	714
2018 Q3	–	Sell	-16	Closed	-$1K	–	1646
2018 Q2	$1K	Buy	+16	New	+$927	﹤0.01%	2132

Other funds holding PPH

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

JSAM

J. Safra Asset Management New York $2.17B AUM 29.66% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Avalon Trust Santa Fe, New Mexico $1.63B AUM 42.75% 1-Year Est. Return

AWC

Adamsbrown Wealth Consultants Wichita, Kansas $530M AUM 23.21% 1-Year Est. Return

Centaurus Financial's PPH Position: Q2 2026 in Review

Centaurus Financial opened a new position in VanEck Pharmaceutical ETF (PPH) in Q2 2026: 1,273 shares worth $139K. The stake represents 0.01% of the portfolio and ranks #995 among its holdings. This is a return to the name: Centaurus Financial previously reported a position in PPH as recently as Q3 2024.

Centaurus Financial first reported a position in PPH in Q2 2018 and has held it in 5 quarters since. 148 funds tracked by Wall St. Rank hold PPH as of Q2 2026.

Centaurus Financial held 1,273 shares of VanEck Pharmaceutical ETF worth $139K as of Q2 2026.
VanEck Pharmaceutical ETF was a new Centaurus Financial position in Q2 2026.
VanEck Pharmaceutical ETF made up 0.01% of Centaurus Financial's portfolio in Q2 2026, its #995 holding.
Centaurus Financial first reported a position in VanEck Pharmaceutical ETF in Q2 2018 and has held it in 5 quarters since.
148 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2026.

Based on Centaurus Financial's 13F filing for Q2 2026, filed 17 Aug 2026.